Evidence map›Paper›PMID 18490780›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2008

Presence of suppressor HIV-specific CD8+ T cells is associated with increased PD-1 expression on effector CD8+ T cells.

Mohamed Elrefaei, Chris A R Baker, Norman G Jones, David R Bangsberg, Huyen Cao

Open access · greenAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 34 citations in OpenAlex.

  1. IL-10-Secreting CD8Pathogens (Basel, Switzerland) · 2022
    Article
  2. FoxP3Frontiers in immunology · 2022
    Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Mohamed ElrefaeiCalifornia Department of Public Health, Richmond, CA 94804, USA. melrefae@cdph.ca.gov
Chris A R Baker
Norman G Jones
David R Bangsberg
Huyen Cao
California Department of Public Health · USUniversity of California, San Francisco · US

Funding

TB PREVENTION AND HIV IN THE HOMELESS--AN INTERVENTIONR01MH054907 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BANGSBERG, DAVID ROY · 1995 to 2014
$20.7M
HIV-1 Fusion CoreceptorsR01AI043885 · NIAID · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI BRODER, CHRISTOPHER C · 1998 to 2008
$1.8M
Mentoring Patient Oriented Adherence Research in UgandaK24MH087227 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI BANGSBERG, DAVID ROY · 2009 to 2013
$776k
HIV-1 Fusion CoreceptorsR21AI043885 · NIAID · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI BRODER, CHRISTOPHER · 2003 to 2003
$299k
Suppressor CD8+ T cells in HIV infectionF32AI071772 · NIAID · PUBLIC HEALTH FOUNDATION ENTERPRISES · PI ELREFAEI, MOHAMED M · 2007 to 2009
$116k
NIAID NIH HHS AI43885NIAID NIH HHS AI71772NIAID NIH HHS F32 AI071772NIAID NIH HHS R01 AI043885NIAID NIH HHS R21 AI043885NIMH NIH HHS K24 MH087227NIMH NIH HHS MH54907NIMH NIH HHS R01 MH054907
6 · The paper itself

Abstract

Mechanisms leading to the observed immune dysregulation in HIV-1 infection are not well understood. HIV-specific IL-10-positive CD8(+) T cells are increased in advanced HIV disease. We have previously reported that Gag-specific IL-10-positive CD8(+) T cells suppressed cytolysis. In this study we describe the suppressive effect of Nef-specific IL-10-positive CD8(+) T cells. Interestingly, simultaneous removal of both Gag- and Nef-specific IL-10-positive CD8(+) T cells led to higher HIV-specific cytolysis compared with the removal of Nef-specific IL-10-positive CD8(+) T cells alone. We also examined the level of programmed cell death-1 (PD-1) as a measure of immune dysfunction in association with IL-10-positive suppressor CD8(+) T cells. The level of PD-1 expression on CD107-positive effector CD8(+) T cells was significantly increased when IL-10-positive suppressor CD8(+) T cells were present (p < 0.05). Our results suggest that IL-10-positive suppressor CD8(+) T cells contribute to the immune dysfunction observed in advanced HIV infection and that the concomitant presence of multiple IL-10-positive CD8(+) T cell populations may have an additive suppressive effect.

Indexed as

AdultAntigens, CDApoptosis Regulatory ProteinsCD8-Positive T-LymphocytesCytotoxicity, Immunologicgag Gene Products, Human Immunodeficiency VirusHIVHIV InfectionsHumansInterleukin-10Middle Agednef Gene Products, Human Immunodeficiency VirusProgrammed Cell Death 1 ReceptorT-Lymphocyte SubsetsTransforming Growth Factor betaAntigens, CDApoptosis Regulatory Proteinsgag Gene Products, Human Immunodeficiency VirusInterleukin-10nef Gene Products, Human Immunodeficiency VirusPDCD1 protein, humanProgrammed Cell Death 1 ReceptorTransforming Growth Factor beta

Identifiers

PMID18490780
PMCPMC3591725
OpenAlexW1541892895

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.